These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19703364)

  • 1. Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.
    Li FQ; Su H; Chen X; Qin XJ; Liu JY; Zhu QG; Hu JH
    J Pharm Pharmacol; 2009 Sep; 61(9):1155-61. PubMed ID: 19703364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.
    Greupink R; Bakker HI; Bouma W; Reker-Smit C; Meijer DK; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2006 May; 317(2):514-21. PubMed ID: 16439617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.
    Greupink R; Bakker HI; Reker-Smit C; van Loenen-Weemaes AM; Kok RJ; Meijer DK; Beljaars L; Poelstra K
    J Hepatol; 2005 Nov; 43(5):884-92. PubMed ID: 16083988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Patel G; Kher G; Misra A
    J Drug Target; 2012 Feb; 20(2):155-65. PubMed ID: 21913877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells.
    Ye Z; Cheng K; Guntaka RV; Mahato RI
    Biochemistry; 2005 Mar; 44(11):4466-76. PubMed ID: 15766277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-circulation of hemoglobin-loaded polymeric nanoparticles as oxygen carriers with modulated surface charges.
    Xu F; Yuan Y; Shan X; Liu C; Tao X; Sheng Y; Zhou H
    Int J Pharm; 2009 Jul; 377(1-2):199-206. PubMed ID: 19454305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells.
    Zhang J; Zhang QS; Chen XM; Tian GY
    Glycoconj J; 2002 Jul; 19(6):423-9. PubMed ID: 14707489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
    Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
    J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated rats.
    Greupink R; Reker-Smit C; Proost JH; van Loenen Weemaes AM; de Hooge M; Poelstra K; Beljaars L
    Biochem Pharmacol; 2007 May; 73(9):1455-62. PubMed ID: 17239825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
    Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
    J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
    Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
    Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
    Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
    Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
    Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
    Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.